LifeMD (NASDAQ:LFMD) versus Concentra Group Holdings Parent (NYSE:CON) Head to Head Comparison

Concentra Group Holdings Parent (NYSE:CON) and LifeMD (NASDAQ:LFMD) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk.

Volatility & Risk

Concentra Group Holdings Parent has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500. Comparatively, LifeMD has a beta of 1.45, indicating that its share price is 45% more volatile than the S&P 500.

Institutional & Insider Ownership

35.5% of LifeMD shares are owned by institutional investors. 6.6% of Concentra Group Holdings Parent shares are owned by insiders. Comparatively, 18.4% of LifeMD shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Concentra Group Holdings Parent and LifeMD’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Concentra Group Holdings Parent	7.33%	48.42%	5.90%
LifeMD	-1.82%	N/A	-6.44%

Analyst Ratings

This is a summary of recent ratings for Concentra Group Holdings Parent and LifeMD, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Concentra Group Holdings Parent	0	2	4	0	2.67
LifeMD	1	2	6	0	2.56

Concentra Group Holdings Parent presently has a consensus price target of $27.75, suggesting a potential upside of 39.67%. LifeMD has a consensus price target of $9.25, suggesting a potential upside of 139.64%. Given LifeMD’s higher possible upside, analysts clearly believe LifeMD is more favorable than Concentra Group Holdings Parent.

Earnings and Valuation

This table compares Concentra Group Holdings Parent and LifeMD”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Concentra Group Holdings Parent	$1.90 billion	1.34	$166.54 million	$1.20	16.56
LifeMD	$212.45 million	0.87	-$18.88 million	($0.17)	-22.71

Concentra Group Holdings Parent has higher revenue and earnings than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than Concentra Group Holdings Parent, indicating that it is currently the more affordable of the two stocks.

Summary

Concentra Group Holdings Parent beats LifeMD on 9 of the 14 factors compared between the two stocks.

About Concentra Group Holdings Parent

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers’ compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.

About LifeMD

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.